Sfoglia per Autore
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trial
2025-01-01 Takada, K.; Takamori, S.; Shimokawa, M.; Pinato, D. J.; Cortellini, A.
Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study
2025-01-01 Lombardi, Pasquale; Kim, Jung Sun; Manfredi, Giulia F.; Celsa, Ciro; Fulgenzi, Claudia A. M.; D'Alessio, Antonio; Stefanini, Bernardo; Doshi, Niraj C.; Warmington, Emily; Marron, Thomas U.; Pinter, Matthias; Scheiner, Bernhard; Kang, Beodeul; Lim, Ho Yeong; Hsu, Wei-Fan; Wietharn, Brooke; Silletta, Marianna; Parisi, Alessandro; Lin, Chun-Yen; Dalbeni, Andrea; Masi, Gianluca; Schönlein, Martin; Von Felden, Johann; Piscaglia, Fabio; Galle, Peter R.; Kudo, Masatoshi; Pressiani, Tiziana; Rimassa, Lorenza; Pirisi, Mario; Cabibbo, Giuseppe; Chon, Hong Jae; Pinato, David J.
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence
2025-01-01 Manfredi, Giulia Francesca; Fulgenzi, Claudia Angela Maria; Celsa, Ciro; Stefanini, Bernardo; D'Alessio, Antonio; Pinter, Matthias; Scheiner, Bernhard; Awosika, Nichola; Brunetti, Leonardo; Lombardi, Pasquale; Latchford, Charles; Lee, Pei-Chang; Huang, Yi-Hsiang; Lin, Chun-Yen; Dalbeni, Andrea; Vogel, Arndt; Galle, Peter R.; Kudo, Masatoshi; Rimassa, Lorenza; Chon, Hong Jae; Cabibbo, Giuseppe; Piscaglia, Fabio; Cammà, Calogero; Pillai, Anjana; Pirisi, Mario; Singal, Amit G.; Pinato, David J.
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis
2025-01-01 Celsa, Ciro; Di Maria, Gabriele; Lombardi, Pasquale; D'Alessio, Antonio; Fulgenzi, Claudia A M; Brunetti, Leonardo; Manfredi, Giulia F; Stefanini, Bernardo; Sparacino, Alba; Rigamonti, Cristina; Pirisi, Mario; Latchford, Charles; Vaccaro, Marco; Enea, Marco; Cammà, Calogero; Cabibbo, Giuseppe; Pinato, David James
ctDNA: A Gateway for Personalized Risk Stratification in Surgically Resectable Hepatocellular Cancer
2025-01-01 Pinato, David J; Lombardi, Pasquale; D'Alessio, Antonio; Torkpour, Aria; Fulgenzi, Claudia Angela Maria; Brunetti, Leonardo
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future
2024-01-01 Singal, A. G.; Yarchoan, M.; Yopp, A.; Sapisochin, G.; Pinato, D. J.; Pillai, A.
Beyond Time and Space: Charting Dynamic Evolution of Sporadic Colorectal Cancer
2024-01-01 Lombardi, P.; Pinato, D. J.
Immunotherapy at all stages of hepatocellular carcinoma
2024-01-01 Pinato, D. J.; Fulgenzi, C. A. M.; D'Alessio, A.
Fecal Microbiota Transplantation to Reverse Host-Related Determinants of Resistance to Anticancer Immunotherapy
2024-01-01 D'Arienzo, P. D.; Pinato, D. J.
Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison
2024-01-01 Agirrezabal, I.; Bouattour, M.; Pinato, D. J.; D'Alessio, A.; Brennan, V. K.; Carion, P. L.; Shergill, S.; Amoury, N.; Vilgrain, V.
Inflammation as a Pathogenic Mechanism of Colonic Neoplasia in Primary Sclerosing Cholangitis
2024-01-01 Manfredi, G. F.; Pinato, D. J.
Immunotherapy vs Best Supportive Care for Patients with Hepatocellular Cancer with Child-Pugh B Dysfunction
2024-01-01 Fulgenzi, C. A. M.; Scheiner, B.; D'Alessio, A.; Mehan, A.; Manfredi, G. F.; Celsa, C.; Nishida, N.; Ang, C.; Marron, T. U.; Wu, L.; Saeed, A.; Wietharn, B.; Cammarota, A.; Pressiani, T.; Pinter, M.; Sharma, R.; Cheon, J.; Huang, Y. -H.; Lee, P. -C.; Phen, S.; Gampa, A.; Pillai, A.; Napolitano, A.; Vivaldi, C.; Salani, F.; Masi, G.; Silletta, M.; Lo Prinzi, F.; Di Giacomo, E.; Vincenzi, B.; Bettinger, D.; Thimme, R.; Vogel, A.; Schonlein, M.; Von Felden, J.; Schulze, K.; Wege, H.; Galle, P. R.; Pirisi, M.; Park, J. -W.; Kudo, M.; Rimassa, L.; Singal, A. G.; El Tomb, P.; Ulahannan, S.; Parisi, A.; Chon, H. J.; Hsu, W. -F.; Ghittoni, G.; Camma, C.; Stefanini, B.; Trevisani, F.; Giannini, E. G.; Cortellini, A.; Pinato, D. J.
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024-01-01 Hedayat, S.; Cascione, L.; Cunningham, D.; Schirripa, M.; Lampis, A.; Hahne, J. C.; Tunariu, N.; Hong, S. P.; Marchetti, S.; Khan, K.; Fontana, E.; Angerilli, V.; Delrieux, M.; Rodrigues, D. N.; Procaccio, L.; Rao, S.; Watkins, D.; Starling, N.; Chau, I.; Braconi, C.; Fotiadis, N.; Begum, R.; Guppy, N.; Howell, L.; Valenti, M.; Cribbes, S.; Kolozsvari, B.; Kirkin, V.; Lonardi, S.; Ghidini, M.; Passalacqua, R.; Elghadi, R.; Magnani, L.; Pinato, D. J.; Di Maggio, F.; Ghelardi, F.; Sottotetti, E.; Vetere, G.; Ciraci, P.; Vlachogiannis, G.; Pietrantonio, F.; Cremolini, C.; Cortellini, A.; Loupakis, F.; Fassan, M.; Valeri, N.
Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival
2024-01-01 Yang, L.; Murthy, S.; Cortellini, A.; Lim, E. A.; Gonzalez, M.; Pinato, D. J.; Abdel-Malek, M.; Mahmoud, S.; Martin, N. M.
Circulating tumor DNA dynamics and clinical outcome in metastatic colorectal cancer patients undergoing front-line chemotherapy
2024-01-01 Ghidini, Michele; Hahne, Jens C; Senti, Chiara; Heide, Timon; Proszek, Paula Z; Shaikh, Ridwan; Carter, Paul; Hubank, Michael; Trevisani, Francesco; Garrone, Ornella; Cappelletti, Maria Rosa; Generali, Daniele; Cattaneo, Monica; Gnocchi, Nicoletta; Donati, Gianvito; Gobbi, Angela; Grizzi, Giulia; Lampis, Andrea; Elghadi, Raghad; Tanzi, Giulia; Tomasello, Gianluca; Ratti, Margherita; Pinato, David J; Fassan, Matteo; Vlachogiannis, Georgios; Sottoriva, Andrea; Passalacqua, Rodolfo; Valeri, Nicola
Immunotherapy Benefit Over Best Supportive Care in Hepatocellular Cancer With Child-Pugh B Dysfunction-Reply
2024-01-01 Fulgenzi, Claudia A M; D'Alessio, Antonio; Pinato, David J
Early hepatic decompensation identifies patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab or Sorafenib at highest risk of death
2024-01-01 Cabibbo, Giuseppe; Celsa, Ciro; Battaglia, Salvatore; Enea, Marco; Di Maria, Gabriele; Grova, Alessandro; Ciccia, Roberta; Manfredi, Giulia F; Iavarone, Massimo; Vogel, Arndt; Singal, Amit G; Reig, Maria; Pinato, David J; Cammà, Calogero
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma
2024-01-01 Talukder, Rafee; Bakaloudi, Dimitra Rafailia; Makrakis, Dimitrios; Diamantopoulos, Leonidas N; Enright, Thomas; Leary, Jacob B; Raychaudhuri, Ruben; Tripathi, Nishita; Agarwal, Neeraj; Jindal, Tanya; Brown, Jason R; Zakharia, Yousef; Rey-Cárdenas, Macarena; Castellano, Daniel; Nguyen, Charles B; Alva, Ajjai; Zakopoulou, Roubini; Bamias, Aristotelis; Barrera, Rafael Morales; Marmolejo, David; Drakaki, Alexandra; Pinato, David J; Korolewicz, James; Buznego, Lucia Alonso; Duran, Ignacio; Carballeira, Clara Castro; Mckay, Rana R; Stewart, Tyler F; Gupta, Shilpa; Barata, Pedro; Yu, Evan Y; Koshkin, Vadim S; Khaki, Ali Raza; Grivas, Petros
Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
2024-01-01 Cappuyns, Sarah; Piqué-Gili, Marta; Esteban-Fabró, Roger; Philips, Gino; Balaseviciute, Ugne; Pinyol, Roser; Gris-Oliver, Albert; Vandecaveye, Vincent; Abril-Fornaguera, Jordi; Montironi, Carla; Bassaganyas, Laia; Peix, Judit; Zeitlhoefler, Marcus; Mesropian, Agavni; Huguet-Pradell, Júlia; Haber, Philipp K; Figueiredo, Igor; Ioannou, Giorgio; Gonzalez-Kozlova, Edgar; D'Alessio, Antonio; Mohr, Raphael; Meyer, Tim; Lachenmayer, Anja; Marquardt, Jens U; Reeves, Helen L; Edeline, Julien; Finkelmeier, Fabian; Trojan, Jörg; Galle, Peter R; Foerster, Friedrich; Mínguez, Beatriz; Montal, Robert; Gnjatic, Sacha; Pinato, David J; Heikenwalder, Mathias; Verslype, Chris; Van Cutsem, Eric; Lambrechts, Diether; Villanueva, Augusto; Dekervel, Jeroen; Llovet, Josep M
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?
2024-01-01 Smirne, Carlo; Crobu, Maria Grazia; Landi, Irene; Vercellino, Nicole; Apostolo, Daria; Pinato, David James; Vincenzi, Federica; Minisini, Rosalba; Tonello, Stelvio; D'Onghia, Davide; Ottobrelli, Antonio; Martini, Silvia; Bracco, Christian; Fenoglio, Luigi Maria; Campanini, Mauro; Berton, Alessandro Maria; Ciancio, Alessia; Pirisi, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trial | 1-gen-2025 | Takada, K.; Takamori, S.; Shimokawa, M.; Pinato, D. J.; Cortellini, A. | |
| Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study | 1-gen-2025 | Lombardi, Pasquale; Kim, Jung Sun; Manfredi, Giulia F.; Celsa, Ciro; Fulgenzi, Claudia A. M.; D'Alessio, Antonio; Stefanini, Bernardo; Doshi, Niraj C.; Warmington, Emily; Marron, Thomas U.; Pinter, Matthias; Scheiner, Bernhard; Kang, Beodeul; Lim, Ho Yeong; Hsu, Wei-Fan; Wietharn, Brooke; Silletta, Marianna; Parisi, Alessandro; Lin, Chun-Yen; Dalbeni, Andrea; Masi, Gianluca; Schönlein, Martin; Von Felden, Johann; Piscaglia, Fabio; Galle, Peter R.; Kudo, Masatoshi; Pressiani, Tiziana; Rimassa, Lorenza; Pirisi, Mario; Cabibbo, Giuseppe; Chon, Hong Jae; Pinato, David J. | |
| Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence | 1-gen-2025 | Manfredi, Giulia Francesca; Fulgenzi, Claudia Angela Maria; Celsa, Ciro; Stefanini, Bernardo; D'Alessio, Antonio; Pinter, Matthias; Scheiner, Bernhard; Awosika, Nichola; Brunetti, Leonardo; Lombardi, Pasquale; Latchford, Charles; Lee, Pei-Chang; Huang, Yi-Hsiang; Lin, Chun-Yen; Dalbeni, Andrea; Vogel, Arndt; Galle, Peter R.; Kudo, Masatoshi; Rimassa, Lorenza; Chon, Hong Jae; Cabibbo, Giuseppe; Piscaglia, Fabio; Cammà, Calogero; Pillai, Anjana; Pirisi, Mario; Singal, Amit G.; Pinato, David J. | |
| Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis | 1-gen-2025 | Celsa, Ciro; Di Maria, Gabriele; Lombardi, Pasquale; D'Alessio, Antonio; Fulgenzi, Claudia A M; Brunetti, Leonardo; Manfredi, Giulia F; Stefanini, Bernardo; Sparacino, Alba; Rigamonti, Cristina; Pirisi, Mario; Latchford, Charles; Vaccaro, Marco; Enea, Marco; Cammà, Calogero; Cabibbo, Giuseppe; Pinato, David James | |
| ctDNA: A Gateway for Personalized Risk Stratification in Surgically Resectable Hepatocellular Cancer | 1-gen-2025 | Pinato, David J; Lombardi, Pasquale; D'Alessio, Antonio; Torkpour, Aria; Fulgenzi, Claudia Angela Maria; Brunetti, Leonardo | |
| Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future | 1-gen-2024 | Singal, A. G.; Yarchoan, M.; Yopp, A.; Sapisochin, G.; Pinato, D. J.; Pillai, A. | |
| Beyond Time and Space: Charting Dynamic Evolution of Sporadic Colorectal Cancer | 1-gen-2024 | Lombardi, P.; Pinato, D. J. | |
| Immunotherapy at all stages of hepatocellular carcinoma | 1-gen-2024 | Pinato, D. J.; Fulgenzi, C. A. M.; D'Alessio, A. | |
| Fecal Microbiota Transplantation to Reverse Host-Related Determinants of Resistance to Anticancer Immunotherapy | 1-gen-2024 | D'Arienzo, P. D.; Pinato, D. J. | |
| Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison | 1-gen-2024 | Agirrezabal, I.; Bouattour, M.; Pinato, D. J.; D'Alessio, A.; Brennan, V. K.; Carion, P. L.; Shergill, S.; Amoury, N.; Vilgrain, V. | |
| Inflammation as a Pathogenic Mechanism of Colonic Neoplasia in Primary Sclerosing Cholangitis | 1-gen-2024 | Manfredi, G. F.; Pinato, D. J. | |
| Immunotherapy vs Best Supportive Care for Patients with Hepatocellular Cancer with Child-Pugh B Dysfunction | 1-gen-2024 | Fulgenzi, C. A. M.; Scheiner, B.; D'Alessio, A.; Mehan, A.; Manfredi, G. F.; Celsa, C.; Nishida, N.; Ang, C.; Marron, T. U.; Wu, L.; Saeed, A.; Wietharn, B.; Cammarota, A.; Pressiani, T.; Pinter, M.; Sharma, R.; Cheon, J.; Huang, Y. -H.; Lee, P. -C.; Phen, S.; Gampa, A.; Pillai, A.; Napolitano, A.; Vivaldi, C.; Salani, F.; Masi, G.; Silletta, M.; Lo Prinzi, F.; Di Giacomo, E.; Vincenzi, B.; Bettinger, D.; Thimme, R.; Vogel, A.; Schonlein, M.; Von Felden, J.; Schulze, K.; Wege, H.; Galle, P. R.; Pirisi, M.; Park, J. -W.; Kudo, M.; Rimassa, L.; Singal, A. G.; El Tomb, P.; Ulahannan, S.; Parisi, A.; Chon, H. J.; Hsu, W. -F.; Ghittoni, G.; Camma, C.; Stefanini, B.; Trevisani, F.; Giannini, E. G.; Cortellini, A.; Pinato, D. J. | |
| Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer | 1-gen-2024 | Hedayat, S.; Cascione, L.; Cunningham, D.; Schirripa, M.; Lampis, A.; Hahne, J. C.; Tunariu, N.; Hong, S. P.; Marchetti, S.; Khan, K.; Fontana, E.; Angerilli, V.; Delrieux, M.; Rodrigues, D. N.; Procaccio, L.; Rao, S.; Watkins, D.; Starling, N.; Chau, I.; Braconi, C.; Fotiadis, N.; Begum, R.; Guppy, N.; Howell, L.; Valenti, M.; Cribbes, S.; Kolozsvari, B.; Kirkin, V.; Lonardi, S.; Ghidini, M.; Passalacqua, R.; Elghadi, R.; Magnani, L.; Pinato, D. J.; Di Maggio, F.; Ghelardi, F.; Sottotetti, E.; Vetere, G.; Ciraci, P.; Vlachogiannis, G.; Pietrantonio, F.; Cremolini, C.; Cortellini, A.; Loupakis, F.; Fassan, M.; Valeri, N. | |
| Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival | 1-gen-2024 | Yang, L.; Murthy, S.; Cortellini, A.; Lim, E. A.; Gonzalez, M.; Pinato, D. J.; Abdel-Malek, M.; Mahmoud, S.; Martin, N. M. | |
| Circulating tumor DNA dynamics and clinical outcome in metastatic colorectal cancer patients undergoing front-line chemotherapy | 1-gen-2024 | Ghidini, Michele; Hahne, Jens C; Senti, Chiara; Heide, Timon; Proszek, Paula Z; Shaikh, Ridwan; Carter, Paul; Hubank, Michael; Trevisani, Francesco; Garrone, Ornella; Cappelletti, Maria Rosa; Generali, Daniele; Cattaneo, Monica; Gnocchi, Nicoletta; Donati, Gianvito; Gobbi, Angela; Grizzi, Giulia; Lampis, Andrea; Elghadi, Raghad; Tanzi, Giulia; Tomasello, Gianluca; Ratti, Margherita; Pinato, David J; Fassan, Matteo; Vlachogiannis, Georgios; Sottoriva, Andrea; Passalacqua, Rodolfo; Valeri, Nicola | |
| Immunotherapy Benefit Over Best Supportive Care in Hepatocellular Cancer With Child-Pugh B Dysfunction-Reply | 1-gen-2024 | Fulgenzi, Claudia A M; D'Alessio, Antonio; Pinato, David J | |
| Early hepatic decompensation identifies patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab or Sorafenib at highest risk of death | 1-gen-2024 | Cabibbo, Giuseppe; Celsa, Ciro; Battaglia, Salvatore; Enea, Marco; Di Maria, Gabriele; Grova, Alessandro; Ciccia, Roberta; Manfredi, Giulia F; Iavarone, Massimo; Vogel, Arndt; Singal, Amit G; Reig, Maria; Pinato, David J; Cammà, Calogero | |
| Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma | 1-gen-2024 | Talukder, Rafee; Bakaloudi, Dimitra Rafailia; Makrakis, Dimitrios; Diamantopoulos, Leonidas N; Enright, Thomas; Leary, Jacob B; Raychaudhuri, Ruben; Tripathi, Nishita; Agarwal, Neeraj; Jindal, Tanya; Brown, Jason R; Zakharia, Yousef; Rey-Cárdenas, Macarena; Castellano, Daniel; Nguyen, Charles B; Alva, Ajjai; Zakopoulou, Roubini; Bamias, Aristotelis; Barrera, Rafael Morales; Marmolejo, David; Drakaki, Alexandra; Pinato, David J; Korolewicz, James; Buznego, Lucia Alonso; Duran, Ignacio; Carballeira, Clara Castro; Mckay, Rana R; Stewart, Tyler F; Gupta, Shilpa; Barata, Pedro; Yu, Evan Y; Koshkin, Vadim S; Khaki, Ali Raza; Grivas, Petros | |
| Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma | 1-gen-2024 | Cappuyns, Sarah; Piqué-Gili, Marta; Esteban-Fabró, Roger; Philips, Gino; Balaseviciute, Ugne; Pinyol, Roser; Gris-Oliver, Albert; Vandecaveye, Vincent; Abril-Fornaguera, Jordi; Montironi, Carla; Bassaganyas, Laia; Peix, Judit; Zeitlhoefler, Marcus; Mesropian, Agavni; Huguet-Pradell, Júlia; Haber, Philipp K; Figueiredo, Igor; Ioannou, Giorgio; Gonzalez-Kozlova, Edgar; D'Alessio, Antonio; Mohr, Raphael; Meyer, Tim; Lachenmayer, Anja; Marquardt, Jens U; Reeves, Helen L; Edeline, Julien; Finkelmeier, Fabian; Trojan, Jörg; Galle, Peter R; Foerster, Friedrich; Mínguez, Beatriz; Montal, Robert; Gnjatic, Sacha; Pinato, David J; Heikenwalder, Mathias; Verslype, Chris; Van Cutsem, Eric; Lambrechts, Diether; Villanueva, Augusto; Dekervel, Jeroen; Llovet, Josep M | |
| Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? | 1-gen-2024 | Smirne, Carlo; Crobu, Maria Grazia; Landi, Irene; Vercellino, Nicole; Apostolo, Daria; Pinato, David James; Vincenzi, Federica; Minisini, Rosalba; Tonello, Stelvio; D'Onghia, Davide; Ottobrelli, Antonio; Martini, Silvia; Bracco, Christian; Fenoglio, Luigi Maria; Campanini, Mauro; Berton, Alessandro Maria; Ciancio, Alessia; Pirisi, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile